Roivant Sciences (NASDAQ:ROIV) is gearing up to announce its quarterly earnings on Friday, 2026-02-06. Here's a quick overview of what investors should know before the release. Analysts are estimating ...
Roivant SciencesROIV unveiled "exceptional" results Friday for its skin disease treatment, sending the biotech stock flying back above its 50-day line. Roivant subsidiary Proivant Therapeutics tested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results